Target Engagement And Evidence Of Efficacy With Pxl770, A Novel Direct Amp-Kinase Activator, In A 4-Week Pk/Pd Trial In Patients With NafldVlad Ratziu,Julie Dubourg,David Moller,Sebastien Bolze,Sophie Bozec,Pascale Fouqueray,Kenneth Cusi,Stephen HarrisonJOURNAL OF HEPATOLOGY(2021)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要